-
"Pharmaceutical Speed Reading Club" Takeda Natpara is short of cefuroxime, arkamicin...
Time of Update: 2021-05-02
[April 7, 2021/Medical Information List] Revised instructions for cefuroxime and arkamicin; Microchip Biotech "Cioroni Capsules" launched Phase III clinical trials for small cell lung cancer; Hengrui HR19042 capsules were approved It is used to treat primary IgA nephropathy; Takeda's 100 microgram dose of Natpara will be cut off for 1 year.
-
The State Food and Drug Administration revises the drug instructions for cefuroxime oral preparations and injection preparations
Time of Update: 2021-04-24
Post-marketing surveillance found that this product had case reports of angioedema, severe allergic-like reactions, and anaphylactic shock.
Post-marketing monitoring found that this product still has case reports of hematuria, interstitial nephritis, and acute kidney injury (including acute renal failure).
-
Consistency evaluation of cefuroxime axetil capsule
Time of Update: 2019-12-03
On December 2, Shanghai Hyundai Pharmaceutical Co., Ltd announced that its holding subsidiary, Sinopharm Zhijun (Shenzhen) Pharmaceutical Co., Ltd (hereinafter referred to as "Sinopharm Zhijun"), had
-
The results show that cefuroxime sodium for injection is well tolerated
Time of Update: 2009-11-10
The drug is mainly used for Staphylococcus aureus (including penicillin resistant strains, except for a few methicillin resistant strains), Staphylococcus epidermidis, Haemophilus influenzae, Escheri
-
Yifan Pharmaceutical's Cefuroxime Sodium for Injection passed the consistency evaluation of generic drugs
Time of Update: 2022-05-29
Cefuroxime sodium for injection is a second-generation cephalosporin antibiotic, mainly used for infections caused by sensitive bacteria, including respiratory tract infections, ENT infections, urinary tract infections, skin and soft tissue infections, sepsis, meningitis, gonorrhea, Bone and joint infections, puerperium and gynecological infections .
com, the sales of cefuroxime sodium for injection in China in 2019 and 2020 were 5.
-
Cefuroxime Sodium for Injection passed the consistency evaluation of generic drugs
Time of Update: 2022-03-07
(hereinafter referred to as the "Company"), received the "Supplementary Drug Application for Cefuroxime Sodium for Injection" approved and issued by the State Drug Administration.
Cefuroxime Sodium for Injection is Yifan Yosemite Pharmaceutical Technology Co.
jointly invested and established by the company's two wholly-owned subsidiaries, Zhejiang Jutai Pharmaceutical Co.
-
Baiyunshan: Cefuroxime sodium for injection passed the consistency evaluation of generic drugs
Time of Update: 2021-08-11
On June 22, Baiyunshan announced that its subsidiary Tianxin Pharmaceutical's cefuroxime sodium for injection has passed the consistency evaluation of generic drugs .
According to public information, the domestic manufacturers of cefuroxime sodium for injection that have passed or deemed to have passed the consistency evaluation include Zhejiang Huidisen Pharmaceutical Co.